News Conference News ESC 2017 BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months Shelley Wood August 30, 2017
News Conference News ESC 2017 CHANGE DAPT: Study Contests Benefit of Ticagrelor Over Clopidogrel After PCI in ACS Todd Neale August 30, 2017
News Conference News ESC 2017 VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost? Shelley Wood August 28, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Daily News Fibrinolytic Agents for STEMI: Meta-analysis Explores the Differences Todd Neale August 18, 2017
News Daily News FDA: Class I Recall for Cook’s Thoracic Endovascular Grafts Michael O'Riordan August 17, 2017
News Daily News FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints Michael O'Riordan August 16, 2017
News Daily News One in Four ICD Patients Need Reintervention Within 5 Years Ashley Lyles August 04, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Daily News Boston Scientific Scraps Biodegradable Scaffold Program Michael O'Riordan August 01, 2017
News Industry News Keystone Heart Ltd to Accelerate Trials for Advanced Device to Protect Brain During Heart Procedures August 01, 2017
News Daily News Despite the Strengths of Next-Gen DES, BMS Deserve a Place at the Cath Table, Review Asserts Caitlin E. Cox July 28, 2017
News Daily News Palliative Care Ups Quality of Life, Mental Health for HF Patients Caitlin E. Cox July 19, 2017
News Daily News TAVR Equivalent to Surgery in Real-World Practice, New Analysis Shows Michael O'Riordan July 17, 2017
News Daily News Mystery of Global Bacterial Outbreak Among Cardiothoracic Surgery Patients Solved With Genomic Sequencing L.A. McKeown July 14, 2017
News Daily News Inferior Vena Cava Filter Use Fell After FDA Warning but Remains High Todd Neale July 12, 2017
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017